Impact of Precision Medicine in Oncology Immuno-oncology

被引:0
|
作者
Buchbinder, Elizabeth I. [1 ,2 ,3 ,5 ]
Hodi, F. Stephen [1 ,2 ,3 ,4 ]
机构
[1] Dana Farber Canc Inst, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA
[2] Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Med, Boston, MA USA
[3] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA USA
[4] Dana Farber Canc Inst, Ctr Immuno Oncol, Boston, MA USA
[5] 450 Brookline Ave, Boston, MA 02215 USA
来源
CANCER JOURNAL | 2023年 / 29卷 / 01期
关键词
CAR-T cell; immune checkpoint inhibition; immunotherapy; cellular therapy; cytokine; TIL therapy; INTERLEUKIN-2 HD IL-2; RENAL-CELL CARCINOMA; METASTATIC MELANOMA; T-CELLS; PD-1; CTLA-4; THERAPY; IMMUNOTHERAPY; IPILIMUMAB; BLOCKADE;
D O I
10.1097/PPO.0000000000000641
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cancer treatment has dramatically changed over the last decade with the development of immunotherapy. Therapies including immune cytokines, immune checkpoint inhibition, intratumoral therapies, and cellular therapies are already widely used in the oncology clinic. Active development continues in these areas and in the development of vaccines, bispecific therapies, and more refined cellular therapies. In this review, we will examine the role that immune therapy has in cancer treatment and explore areas of future development.
引用
收藏
页码:15 / 19
页数:5
相关论文
共 50 条
  • [21] Novel Nuclear Medicine Imaging Applications in Immuno-Oncology
    Frega, Stefano
    Dal Maso, Alessandro
    Pasello, Giulia
    Cuppari, Lea
    Bonanno, Laura
    Conte, PierFranco
    Evangelista, Laura
    CANCERS, 2020, 12 (05)
  • [22] Virtual Issue: Oncology, Immunology, and Immuno-oncology
    Muller, Christa E.
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2021, 4 (05) : 1475 - 1475
  • [23] Interventional Oncology and Immuno-oncology Status Quo
    Helmberger, Thomas
    RADIOLOGE, 2020, 60 (08): : 681 - 681
  • [24] Precision Immuno-Oncology in NSCLC through Gender Equity Lenses
    Marks, Jennifer
    Sridhar, Arthi
    Ai, Angela
    Kiel, Lauren
    Kaufman, Rebekah
    Abioye, Oyepeju
    Mantz, Courtney
    Florez, Narjust
    CANCERS, 2024, 16 (07)
  • [25] Precision Immuno-Oncology: Prospects of Individualized Immunotherapy for Pancreatic Cancer
    Zhang, Jiajia
    Wolfgang, Christopher L.
    Zheng, Lei
    CANCERS, 2018, 10 (02)
  • [26] Immuno-Oncology in Cancer Care is a Fantastic Opportunity for Interventional Oncology: IO4IO (Interventional Oncology for Immuno-Oncology) Initiative
    Thierry de Baère
    Lambros Tselikas
    Frederic Deschamps
    Jean Charles Soria
    Aurélien Marabelle
    CardioVascular and Interventional Radiology, 2018, 41 : 825 - 827
  • [27] Immuno-Oncology in Cancer Care is a Fantastic Opportunity for Interventional Oncology: IO4IO (Interventional Oncology for Immuno-Oncology) Initiative
    de Baere, Thierry
    Tselikas, Lambros
    Deschamps, Frederic
    Soria, Jean Charles
    Marabelle, Aurelien
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2018, 41 (06) : 825 - 827
  • [28] Outlook: Future of Immuno-oncology
    不详
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (12)
  • [29] Regional hyperthermia and immuno-oncology
    Issels, R.
    Lindner, L.
    Buecklein, V.
    Multhoff, G.
    Salat, C.
    von Bergwelt, M.
    Noessner, E.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2018, 194 (05) : 483 - 484
  • [30] Neoantigens in the immuno-oncology space
    Arlen, Philip M.
    FUTURE ONCOLOGY, 2017, 13 (25) : 2209 - 2211